98%
921
2 minutes
20
Background: The role of loop diuretics in patients with acute kidney injury (AKI) is controversial. This study examined the association between the use of loop diuretics and prognosis in critically ill patients with AKI.
Methods: This study used data from the medical information mart for the intensive care IV database. Adult critically ill patients with AKI were included in the analysis. Patients were partitioned into two groups based on their use of loop diuretics in the ICU, and potentially confounding variables between the two groups were balanced using propensity score matching (PSM). We used time-dependent Cox proportional hazards regression, logistic regression, and Hodges-Lehman estimator to assess the impact of loop diuretics on all-cause mortality, renal replacement therapy (RRT) use, and the length of hospital stay, respectively.
Results: This study included a cohort of 19,671 patients. After PSM, both groups consisted of 6200 patients. The use of loop diuretics was associated with a lower risk of in-hospital mortality (HR, 0.672; 95% CI 0.597-0.757; P < 0.001), lower in-ICU mortality (HR, 0.375; 95% CI 0.315-0.446; P < 0.001), and lower odds of in-hospital RRT (OR, 0.472; 95% CI 0.400-0.555; P < 0.001). A sensitivity analysis using the original cohort (HR, 0.624; 95% CI 0.561-0.693; P < 0.001) and weighted cohort (HR, 0.654; 95% CI 0.582-0.736; P < 0.001) also demonstrated lower in-hospital all-cause mortality.
Conclusions: The use of loop diuretics is associated with a substantial reduction in mortality among critically ill patients with AKI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11255-024-04271-7 | DOI Listing |
Cureus
August 2025
Internal Medicine, Combined Military Hospital, Muzaffarabad, PAK.
This systematic review explores the impact of diuretic timing and strategy on outcomes in patients with acute decompensated heart failure (ADHF). A total of seven studies were included, comprising randomized controlled trials (RCTs), pre-specified sub-analyses, and observational data. Early administration of intravenous loop diuretics, particularly within the first 60 to 90 minutes of hospital arrival, was generally associated with improved short-term outcomes, including reduced in-hospital and 30-day mortality.
View Article and Find Full Text PDFIV loop diuretics remain the cornerstone of treatment for acute decompensated heart failure (ADHF). Although previous meta-analyses have compared continuous infusion and intermittent bolus dosing of IV loop diuretics, their respective renal effects remain unclear. Given the prognostic significance of worsening renal function (WRF) or acute kidney injury in ADHF, evaluating the renal safety of different diuretic regimens is essential.
View Article and Find Full Text PDFIntroduction: Drug-drug interactions (DDIs) have been associated with adverse drug reactions (ADRs) which can cause hospitalization. The aim of this study was to associate potential DDIs (pDDIs) with potential ADRs upon admission to hospital among patients on five internal medicine wards.
Materials And Methods: A cross-sectional study was performed on the cardiology, nephrology, endocrinology, gastroenterology, and geriatrics ward.
J Am Pharm Assoc (2003)
August 2025
Monash Healthxe , 361 Blackburn Rd , Clayton Melbourne, Australia; Monash University Wellington Rd, Clayton . Melbourne Australia; Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia.
Background: There has been increasing interest in the utilisation of health data analytics for decision support systems and prioritising pharmacy clinical work. Despite this potential, there remains limited evidence in the Australian context regarding the design and implementation of data-driven dashboards tailored specifically for pharmacists.
Objectives: We aimed to develop a disease state dashboard in an Australian hospital to assist clinicians identifying and prioritising the review of heart failure (HF) patients when admitted for other reasons, enabling timely optimisation of their care.
Indian Pacing Electrophysiol J
August 2025
Division of Cardiology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY. Electronic address:
Background: Patients with atrial fibrillation (AF) and chronic obstructive pulmonary disease (COPD) are at increased risk of cardiovascular mortality compared to patients with AF alone. Consequently, employing rhythm control strategies such as AF catheter ablation could offer substantial benefits to patients with COPD. However, the impact of COPD on AF ablation outcomes is not well established.
View Article and Find Full Text PDF